期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 188 (3)
Purpose Equivalent efficacy was demonstrated for the biosimilar CT-P6 and trastuzumab following neoadjuvant therapy for patients with human epidermal ......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 187 (3)
Purpose In the KATHERINE study (NCT01772472), patients with HER2-positive early breast cancer (EBC) and residual invasive disease after neoadjuvant ch......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 188 (3)
Background Circulating tumor DNA (ctDNA) provides a promising noninvasive alternative to evaluate the efficacy of neoadjuvant chemotherapy (NCT) in br......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 187 (3)
Purpose HER2-positive breast cancer patients benefit from HER2-targeted therapies, among which the most commonly used is trastuzumab. However, acquire......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 189 (2)
Purpose Epigenetic regulation plays critical roles in cancer progression, and high-frequency mutations or expression variations in epigenetic regulato......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 188 (2)
Purpose We conducted a single-arm prospective phase II trial to evaluate the efficacy and safety of oral metronomic vinorelbine combined with trastuzu......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 188 (2)
Purpose Prior studies have noted that zinc finger E-box binding homeobox 1 (ZEB1) is a master transcription regulator, affecting the expression of nea......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 187 (2)
Purpose Metastasis is the main cause of breast cancer mortality. Recent studies have proved that lipid metabolic reprogramming plays critical roles in......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 188 (2)
Purpose To characterize health-related quality of life (HRQoL) in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic br......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 189 (2)
Purpose A dense breast on mammogram is a strong risk factor for breast cancer. Identifying factors that reduce mammographic breast density could thus ......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 188 (1)
Purpose Therapeutic efficacy of hormonal therapies to target estrogen receptor (ER)-positive breast cancer is limited by the acquisition of ligand-ind......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 189 (2)
Purpose Mutations in hereditary breast cancer genes play an important role in the risk for cancer. Methods Cancer susceptibility genes were sequenced ......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 189 (2)
Purpose In addition to impacting incidence, risk factors for breast cancer may also influence recurrence and survival from the disease. However, it is......
期刊： BREAST CANCER RESEARCH AND TREATMENT, 2021; 188 (2)
Introduction Neoadjuvant endocrine therapy is often utilized to downstage Estrogen Receptor-positive (ER+) breast cancer prior to surgery. However, th......
期刊： BREAST CANCER RESEARCH AND TREATMENT, ; ()
Background Studies evaluating role of BRCA mutations on the survival outcomes in breast cancer (BC) patients have given confounding results and hence,......
